| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 431.98B | 481.25B | 427.67B | 433.85B | 377.30B | 334.79B |
| Gross Profit | 173.79B | 189.45B | 170.67B | 159.82B | 142.48B | 130.80B |
| EBITDA | 20.58B | 24.78B | 20.59B | 25.50B | 18.85B | 17.02B |
| Net Income | 3.43B | 8.74B | 4.54B | 10.90B | 5.68B | 5.99B |
Balance Sheet | ||||||
| Total Assets | 268.66B | 295.21B | 252.81B | 231.13B | 201.80B | 174.38B |
| Cash, Cash Equivalents and Short-Term Investments | 69.26B | 86.66B | 64.81B | 60.07B | 47.50B | 47.85B |
| Total Debt | 135.78B | 145.26B | 119.94B | 100.05B | 81.07B | 59.19B |
| Total Liabilities | 176.52B | 197.02B | 162.34B | 143.77B | 124.59B | 97.18B |
| Stockholders Equity | 92.07B | 98.07B | 90.40B | 87.31B | 77.21B | 77.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.34B | -3.11B | 2.15B | -2.20B | -10.73B |
| Operating Cash Flow | 0.00 | 19.48B | 8.01B | 9.30B | 4.28B | -5.73B |
| Investing Cash Flow | 0.00 | -15.34B | -12.49B | -10.40B | -9.59B | -6.69B |
| Financing Cash Flow | 0.00 | 22.49B | 10.78B | 12.40B | 3.94B | 5.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.84B | 12.04 | ― | 2.19% | 15.14% | 17.01% | |
79 Outperform | ¥33.26B | 10.78 | ― | 3.77% | 17.14% | 8.81% | |
74 Outperform | ¥35.95B | 5.26 | ― | 1.73% | 7.61% | 57.19% | |
67 Neutral | ¥80.32B | 7.71 | ― | 1.81% | 12.53% | 92.28% | |
66 Neutral | ¥12.52B | 5.05 | ― | 0.30% | 6.65% | 28.68% | |
65 Neutral | ¥225.72B | 14.06 | ― | 0.64% | 53.35% | 107.20% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |